NINE people have died in an outbreak of an eye-bleeding disease in Tanzania, Africa’s health agency has announced. This ...
AN outbreak of a lethal ‘eye-bleeding’ virus has been confirmed in Tanzania, the president has announced. It comes just a ...
A SUSPECTED outbreak of a deadly ‘eye bleeding disease’ has sparked fears of a wider spread. So far, the Ebola-like illness ...
Big, goofy, and oh-so-playful, Boxers are a medium-sized, short-haired dog developed in Germany. They are exceedingly playful ...
Hunter syndrome results from the absence of an enzyme needed to break down cellular waste. Without it, waste builds up in the body, causing progressive damage to various systems.
With an FDA approval submission for RegenXBio’s Hunter syndrome gene therapy already underway, the biopharma has now found a commercialization partner for both the U.S. and Asian markets.
Denali’s wholly owned program, DNL310 or tividenofusp alfa, is an Enzyme Transport Vehicle-enabled iduronate-2-sulfatase (IDS) replacement therapy in development for MPS II (Hunter syndrome).
Bow Hunter's Syndrome (BHS) is a rare condition characterized by vertebrobasilar insufficiency, which occurs when the vertebral artery is compressed during head rotation. This compression can lead ...